Mentorship and Research in HIV and Addiction Prevention Among Traumatized Youth

此次K24续订的目的是继续成倍提高Carla Kmett Danielson博士的导师地位 和减少艾滋病毒感染和成瘾风险的创新方法的研究方案 青少年，特别关注受创伤影响的人群。在之前的K24资助期内，Dr。 丹尼尔森是一位临床心理学家和科学家，她证明了她是这种机制的理想候选者。这个 她在扩大研究和指导方面的受保护时间的影响通过众多成就显而易见。 在这一资助期内，包括对23名受训者进行富有成效的指导(50%来自任职人数不足 背景)，表彰这种指导的奖项，在移动健康艾滋病毒和成瘾方面的新研究 预防干预和持续的联邦资助，她的创新的以患者为中心的研究(POR)在 她让她的指导者参与其中。她的导师包括职业生涯早期的教职员工、博士后研究员， 和心理学博士后实习生，正在为预防艾滋病毒、药物滥用、 和创伤应激领域，通过高影响力的出版物和NIH资助的研究的新路线。这个 拟议的K24奖励续期对于为候选人提供必要的时间和资源至关重要 扩大她在虚拟现实技术方面的研究技能，为感染艾滋病毒的高危青少年提供服务，并 上瘾，支持她的指导计划和能力，并进一步刺激她的研究计划 学员(例如，通过在前一个资助期取得成功的学员试点奖励计划)。 Danielson博士在K24更新下提出的创新研究涉及改进和评估 改善创伤的虚拟现实临床工具--物质使用和性行为的知情评估和预防 与处于危险中的年轻人进行危险行为。这将通过顶尖专家的投入和培训来实现 在虚拟现实-高风险行为研究领域；虚拟现实领域的国际知名科技公司 工具开发(虚拟更好公司)；定性研究；消费者和专家咨询委员会；以及 改进的虚拟现实工具对高危人群的有效性、可接受性和可行性评估 (例如，正在接受药物使用问题和创伤应激治疗的青少年；年轻人向 高危艾滋病毒诊所)和卫生保健提供者。丹尼尔森博士提议的辅导活动，目前在联邦- 资助研究项目，目的是在艾滋病毒预防领域进行创新的虚拟现实研究， 减少青少年中物质使用风险和创伤与NIDA的优先事项很好地协调在一起，呼吁 旨在评估提供适应性预防的新技术的应用情况的研究 针对药物使用和预防艾滋病毒感染的干预措施。建议的研究提供了丰富的 为她的受训者提供培训机会(重点是来自临床代表性不足群体的受训者 科学)，并将振兴POR的新方向，使年轻人有感染艾滋病毒和吸毒成瘾的风险。

The purpose of this K24 renewal is to continue to exponentially enhance Dr. Carla Kmett Danielson's mentorship and research program in innovative approaches to risk reduction of HIV acquisition and addiction among adolescents, with a particular focus on trauma-exposed populations. Over the prior K24 funding period, Dr. Danielson, a clinical psychologist and scientist, demonstrated she is the ideal candidate for this mechanism. The impact of her protected time for expanded research and mentorship are evident through numerous achievements from over this funding period, including productive mentorship of 23 mentees (>50% from underrepresented backgrounds), awards in recognition of this mentorship, a new line of research in mHealth HIV and addiction prevention intervention, and continuous federal-funding of her innovative patient oriented research (POR) in which she has involved her mentees. Her mentees, who have included early-career faculty, post-doctoral fellows, and predoctoral psychology interns, are making significant contributions to the HIV prevention, substance abuse, and traumatic stress fields through high-impact publications and new lines of NIH-funded research. The proposed K24 award renewal will be essential for providing the time and resources necessary for the candidate to expand her research skills in virtual reality technologies for young people at high risk for HIV acquisition and addiction, sustain her mentoring program and capacity, and further stimulate the research program of her mentees (e.g., through a trainee pilot award program that was successful during the prior funding period). Innovative research proposed by Dr. Danielson under the K24 renewal involves refinement and evaluation of a virtual reality clinical tool to improve trauma-informed assessment and prevention of substance use and sexual risk behavior with at-risk young people. This will be accomplished through input and training from leading experts in the virtual reality-high risk behavior research field; an internationally known technology firm in virtual reality tool development (Virtually Better, Inc.); qualitative research; an Advisory Board of consumers and experts; and evaluation of the validity, acceptability, and feasibility of the refined virtual reality tool with high risk populations (e.g., adolescents in treatment for substance use problems and traumatic stress; young adults presenting to a high-risk HIV clinic) and health care providers. Dr. Danielson's proposed mentorship activities, current federally- funded research projects, and aims to pursue innovative, virtual reality research in the areas of HIV prevention, substance use risk reduction, and trauma among adolescents harmonize well with NIDA priorities that call for research designed to evaluate the application of new technologies for delivering adapted prevention interventions targeting substance use and prevention of HIV acquisition. The proposed research affords rich training opportunities for her mentees (with an emphasis on trainees from groups under-represented in clinical science) and will invigorate new directions in POR with young people at risk for HIV acquisition and addiction.